Prognostic Significance of Interactions Between ER Alpha and ER Beta and Lymph Node Status in Breast Cancer Cases |
Han, Shu-Jing
(Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University)
Guo, Qing-Qing (Beijing Friend Hospital, Capital University of Medical Sciences) Wang, Ting (Departments of General Surgery, Xinjing Hospital, Xi'an) Wang, You-Xin (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Zhang, Yu-Xiang (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Liu, Fen (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Luo, Yan-Xia (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Zhang, Jie (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Wang, You-Li (Peking University People's Hospital) Yan, Yu-Xiang (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Peng, Xiao-Xia (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) Ling, Rui (Departments of General Surgery, Xinjing Hospital, Xi'an) He, Yan (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University) |
1 | Fleming FJ, Hill AD, McDermott EW, O'Higgins NJ, Young LS (2004). Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J Clin Endocrinol Metab, 89, 375-83. DOI |
2 | Fuqua SA, Schiff R, Parra I, et al (2003). Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res, 63, 2434-9 |
3 | Jarvinen TA, Pelto-Huikko M, Holli K, Isola J (2000). Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol, 156, 29-35. DOI ScienceOn |
4 | Kirschner MA (1977). The role of hormones in the etiology of human breast cancer. Cancer, 39, 2716-26. DOI |
5 | Koda M, Sulkowski S, Kanczuga-Koda L, Surmacz E, Sulkowska M (2004). Expression of ER alpha, ER beta and Ki-67 in primary tumors and lymph node metastases in breast cancer. Oncol Rep, 11, 753-9. |
6 | Lacey JV, Jr., Devesa SS, Brinton LA (2002). Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen, 39, 82-8. DOI ScienceOn |
7 | Lin CY, Strom A, Li Kong S, et al (2007). Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res, 9, R25. DOI |
8 | Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA (2008). A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene, 27, 1019-32. DOI ScienceOn |
9 | Williams G, Anderson E, Howell A, et al (1991) .Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer, 48, 206-10. DOI |
10 | Younes M, Honma N (2011): Estrogen receptor beta. Arch Pathol Lab Med, 135, 63-6. |
11 | Ziegler RG, Anderson WF, Gail MH (2008).Increasing breast cancer incidence in China: the numbers add up. J Natl Cancer Inst, 100, 1339-41. DOI ScienceOn |
12 | Nilsson S, Makela S, Treuter E, et al (2001). Mechanisms of estrogen action. Physiol Rev, 81, 1535-65. |
13 | McGuire WL (1978). Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol, 5, 428-33. |
14 | O'Neill PA, Davies MP, Shaaban AM, et al (2004). Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers. Br J Cancer, 91, 1694-702. |
15 | Murphy L, Cherlet T, Lewis A, Banu Y, Watson P (2003). New insights into estrogen receptor function in human breast cancer. Ann Med, 35, 614-31. DOI ScienceOn |
16 | Omoto Y, Kobayashi S, Inoue S, et al (2002). Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur J Cancer, 38, 380-6. DOI ScienceOn |
17 | Osborne CK (1998). Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat, 51, 227-38. DOI ScienceOn |
18 | Page DL, Fleming ID, Fritz A (2002). AJCC Cancer Staging Manual 6th edition. breast cancer. Lippincott-Raven, Philadelphia, Pa, USA. |
19 | Pettersson K, Delaunay F, Gustafsson JA (2000). Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene, 19, 4970-8. DOI |
20 | Platet N, Cathiard AM, Gleizes M, Garcia M (2004). Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol, 51, 55-67 . DOI ScienceOn |
21 | Rochefort H, Platet N, Hayashido Y, et al (1998).Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol, 65, 163-8. DOI ScienceOn |
22 | Reisenbichler ES, Lester SC, Richardson AL, et al (2013). Interobserver Concordance in Implementing the 2010 ASCO/CAP Recommendations for Reporting ER in Breast Carcinomas: A Demonstration of the Difficulties of Consistently Reporting Low Levels of ER Expression by Manual Quantification. Am J Clin Pathol, 140, 487-94 DOI ScienceOn |
23 | Speirs V, Parkes AT, Kerin MJ, et al (1999).Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res, 59, 525-8. |
24 | Robertson JF (1996). Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer, 73, 5-12. DOI |
25 | Sofi GN, Sofi JN, Nadeem R (2012). Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev, 13, 5047-52 . 과학기술학회마을 DOI ScienceOn |
26 | Sugiura H, Toyama T, Hara Y, et al (2007).Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer. Jpn J Clin Oncol, 37, 820-8 . DOI ScienceOn |
27 | Umemura S, Kurosumi M, Moriya T, et al (2006). Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer, 13, 232-5. DOI ScienceOn |
28 | Jordan VC, Brodie AM (2007).Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids, 72, 7-25. DOI ScienceOn |
![]() |